DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: generic

Plant Construction & Process Technology

Winning Strategies in the Pharmaceutical CDMO Industry

19.09.2018 - Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid...

News

Novartis and Bayer Warn on NHS Eye Drug Plan

21.11.2017 - European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...

Plant Construction & Process Technology

New Rules For Pharma

27.09.2017 - Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...

News

EU Accuses Teva and Cephalon of Antitrust Breach

20.07.2017 - The European Commission has accused Israeli drugmaker Teva and its US subsidiary Cephalon of breaching antitrust rules. Regulators classed an agreement between the companies to...

News

Syngenta-ChemChina Deal Clears US and EU

06.04.2017 - Within two days, one of the three mega mergers influencing in major part the agrochemicals sector moved two steps closer to becoming reality. On Apr. 4-5, the US Federal Trade...

News

China Gets its First Generic Geftinib Drug

22.02.2017 - Chinese drugmaker Qilu Pharmaceutical has introduced a new targeted therapy generic cancer medicine, geftinib, which is claimed to be effective against non-small cell lung cancer...

News

Mylan Faces FTC Investigation on EpiPen

07.02.2017 - US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...

News

Teva Pays $225 Million to Settle Cipro Suit

31.01.2017 - US company Barr Laboratories, a subsidiary of Israeli drugmaker Teva, has reached a $225 million settlement in an antitrust class action that accused Teva of keeping a generic...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.